Development of peptidomimetic boronates as proteasome inhibitors
about
Peptide-based proteasome inhibitors in anticancer drug design.Synthesis and biological evaluation of papain-family cathepsin L-like cysteine protease inhibitors containing a 1,4-benzodiazepine scaffold as antiprotozoal agents.Development of novel selective peptidomimetics containing a boronic acid moiety, targeting the 20S proteasome as anticancer agents.The proteasome of the differently-diverged eukaryote Giardia lamblia and its role in remodeling of the microtubule-based cytoskeleton.Insecticide resistance and intracellular proteases.NMR conformational analysis in solution of a potent class of cysteine proteases inhibitors
P2860
Development of peptidomimetic boronates as proteasome inhibitors
description
article
@en
im Juni 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2013
@uk
name
Development of peptidomimetic boronates as proteasome inhibitors
@en
Development of peptidomimetic boronates as proteasome inhibitors
@nl
type
label
Development of peptidomimetic boronates as proteasome inhibitors
@en
Development of peptidomimetic boronates as proteasome inhibitors
@nl
prefLabel
Development of peptidomimetic boronates as proteasome inhibitors
@en
Development of peptidomimetic boronates as proteasome inhibitors
@nl
P50
P1476
Development of peptidomimetic boronates as proteasome inhibitors
@en
P2093
Kety Scarbaci
Valeria Troiano
P356
10.1016/J.EJMECH.2013.03.032
P50
P577
2013-03-27T00:00:00Z